| Literature DB >> 24206750 |
Jose Antonio Gama Salgado, Martin Kangwa, Marcelo Fernandez-Lahore1.
Abstract
Entities:
Mesh:
Substances:
Year: 2013 PMID: 24206750 PMCID: PMC3828624 DOI: 10.1186/1471-2180-13-250
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
List of microorganisms and plasmids used in this study
| | | |
| TOP10 | F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-leu) 7697 galU galK rpsL (StrR) endA1 nupG | 10 |
| | | |
| X-33 | Wild type | Invitrogen |
| | | |
| DSM 2183 | Wild type | German resource centre for biological material |
| | | |
| pGAPZα-A | The pGAPZα-A vector use the GAP promoter to constitutively express recombinant proteins in | Invitrogen |
| pGAPZα+MCAP | pGAPZα-A derivative carrying the whole | This work |
| pGAPZα+MCAP-2 | pGAPZα-A derivative carrying the | This work |
| pGAPZα+MCAP-3 | pGAPZα-A derivative carrying the | This work |
| pGAPZα+MCAP-5 | pGAPZα-A derivative carrying the | This work |
| pGAPZα+MCAP SP-1 | pGAPZα-A derivative carrying from the amino acid sequence number 67 to 394 of the | This work |
| pGAPZα+SyMCAP-6 | pGAPZα-A derivative carrying the | This work |
1The insert was cloned in frame with the α-factor signal sequence and in frame with the C-terminal polyhistidine tag into the EcoRI and NotI sites of the pGAPZα-A.
2The insert was cloned flush with the Kex2 cleavage site and in a frame of the α-factor signal sequence and in a frame with the C-terminal polyhistidine tag into the XhoI and NotI site of the pGAPZα-A.
Oligonucleotides used for PCR amplification in this study
| Primers for DNA fragment PCR to obtain a partial sequence of genomic DNA of the acid proteinase | |
| 12 ND-F | AACGATATCGAGTACTATGGT |
| M.cir-2R | TTAAAGACTTCATAGTTGTTCTT |
| Primer for 3′-RACE PCR (Gene-specific primer) | |
| GSP-Mucor-1 F | GATGGTCGTGCCTGGTCTATCCAAT |
| Primer for 5′-RACE PCR (gene-specific primer) | |
| GSP-Mucor-2R | CATTGTCTCTGGCACCGTATTGAGCAGC |
| Primers for full-length cDNA and recombinant plasmids | |
| APMC-EcoNaeI-F | ATGGAATTCGCCGGCGCTACTACTGATGCCACTGGTACTGTCCCCG |
| APMC-F | AGGAATTCTTCTCATTAGTCTCTTCTTG |
| APMC-Met-F | ATGGAATTCATGAAATTCTCATTAGTCTCTTCTTGTGTC |
| MCAP-3 F | TATCTCGAG |
| XhoI-N-MCAP-F | TATCTCGAGaaaagaATGAAATTCTCATTAGTCTCTTCTTGTG |
| APMC-NotI-R | AAAGCGGCCGCGACAGATTTGGCAATTT |
| APMC-Stop-R | GTGATTTATAGATAGATAGATGAAATGTACCAAA |
| Primers to identify clones containing recombinant plasmids | |
| pGAP-F | GTCCCTATTTCAATCAATTGAACAAC |
| AOX1pGAP-Rev | CAAATGGCATTCTGACATCCTC |
The underlined sequences (GAATTC; EcoRI, CTCGAG; XhoI and GCGGCCGC; NotI) represent the additional restriction sites at the 5′ ends of forward and reverse primers. The lowercase letters indicate the Kex2 cleavage sites. The primers (for First-strand cDNA synthesis, 3′-RACE cDNA and 5′-RACE cDNA) provided in the SMART RACE cDNA Amplification Kit (Clontech) are not described in the table.
Figure 1Multiple alignment of the consensus motifs sequences NDIEYYG and FLKNNYVVFN of several fungal aspartic proteinases. Consensus motifs sequences are marked in black arrows. Asterisks indicate conserved amino acids. The number to the right of the amino acid sequence is based on the protein.
Figure 2The Nucleotide and deduced amino acid sequence of MCAP protein. The deduced amino acid sequence is shown under the nucleotide sequence. The arrow indicates the proposed signal peptide cleavage site and lowercase letters indicate nucleotides in the intron sequence. The proposed catalytic Asp residues (motifs DTGS and DTGT) are boxed. The potential N-glycosylation site is underlined. Asterisk indicates the position of the stop codon (TAA).
Figure 3SDS-PAGE analysis of the extracellular extract from recombinants X-33/pGAPZα +MCAP-2, X-33/pGAPZα+MCAP-3, X-33/pGAPZα+MCAP-5, X-33/pGAPZα+MCAP-SP1, and X-33 (wild-type). 25 μg of the concentrated protein products were subjected on each lane of SDS-PAGE. Samples: Lane 1, molecular standards (kDa); lane 2, secreted expression from recombinant X-33/pGAPZα+MCAP-5; lane 3, P. pastoris X-33 (negative control); lane 4, X-33/pGAPZα+MCAP-2; lane 5, X-33/pGAPZα+MCAP-3; lane 6, X-33/pGAPZα+MCAP-SP1; and lane 7, secreted expression from M. circinelloides. The asterisk indicates the authentic MCAP. The arrows indicate the expressed forms (A and B) of MCAP protein.
Figure 4SDS-PAGE electrophoretic pattern comparisons of recombinant . (A) Enzymatic analysis of the MCAP protein with endoglycosidase (Endo H). 25 μg of the protein products were digested with endo H and subjected to SDS-PAGE. Lane 1, molecular standards; lane 2, secreted expression from X-33/pGAPZα+MCAP-5 (digested); lane 3, secreted expression from X-33/pGAPZα+MCAP-5 (undigested); lane 4, endo H. The arrows indicate the expressed forms of MCAP protein (above N-glycosylated protein, below the deglycosylated protein, respectively). (B) Analysis of the purified MCAP protein on HiTrap SP Sepharose Fast Flow. Lane 1, molecular standards; lane 2, 10 μg of secreted expression from recombinant X-33/pGAPZα+SyMCAP-6. The arrows indicate the expressed forms of MCAP protein (above N-glycosylated protein, below the deglycosylated protein, respectively).
Figure 5Kinetics and forms of MCAP secreted by recombinant X-33/pGAPZα+MCAP-5 and X-33/pGAPZα+SyMCAP-6. Recombinants were cultured for 24, 48, 72 and 96 hours in YPD medium (initial medium pH: 5.0 and 7.0) at 24°C. Proteins in the sample corresponding to 37 μL of the original supernatant broth were loaded on each lane of SDS-PAGE. Samples: Lane 1, molecular standards (kDa); lanes 2, 3, 4, 5, and 8, secreted expression from recombinant X-33/pGAPZα+MCAP-5 (lane 2, 24 h; lane 3, 48 h; lane 4, 72 h; lane 5, 96 h; lane 8, 72 h); lanes 6, 7, and 9, secreted expression from recombinant X-33/pGAPZα+SyMCAP-6 after 72 hours of cultivation. Lane 7, 4 μg of purified MCAP protein on HiTrap SP Sepharose Fast Flow. The arrows indicate the expressed forms of MCAP protein when the initial pH value of the medium was 5.0 and the lines indicate the expressed forms of MCAP at initial pH of 7.0.
Figure 6Extracellular production of MCAP from recombinant X- 33/pGAPZα+MCAP-5. A) Time course in YPD medium containing 4% glucose at 24°C. B) Production of aspartic proteinase after 72 hours in YPD medium containing 4% glucose. The values shown are the mean activity with standard deviation obtained from three sets of experiments.
Characteristics of the purified recombinant aspartic proteinase (MCAP)
| 33 & 37 | 60 | 3.6 | 40 |
*Enzyme having (2.5 kDa) the additional amino acids of the C-terminal polyhistidine tag.
**Thermal stability of the enzymes at 55°C, for 30 min.
Clotting and proteolytic activities of and aspartic protease
| MCAP | 137 | 7.02 ± 0.28 | 19.5 ± 0.79 |
| 311 | 11.11 ± 0.27 | 28.0 ± 0.68 |
Results shown are the means of three sets of experiments.